{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:11:37Z","timestamp":1793412697474,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10067-016-3413-8","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T07:13:51Z","timestamp":1474528431000},"page":"2915-2923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission"],"prefix":"10.1007","volume":"35","author":[{"given":"Y.","family":"El Miedany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"El Gaafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Bahlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hegazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"3413_CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/annrheumdis-2013-204020","volume":"74","author":"AB Aga","year":"2015","unstructured":"Aga AB, Lie E, Uhlig T et al (2015) Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000\u20132010. Ann Rheum Dis 74:381\u2013388","journal-title":"Ann Rheum Dis"},{"key":"3413_CR2","doi-asserted-by":"publisher","unstructured":"Tanaka Y, Hirata S, Kubo S et al (2013) Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study. Ann Rheum Dis:1\u20137. doi: 10.1136\/annrheumdis-2013-204016","DOI":"10.1136\/annrheumdis-2013-204016"},{"key":"3413_CR3","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/ard.2009.121491","volume":"69","author":"Y Tanaka","year":"2010","unstructured":"Tanaka Y, Takeuchi T, Mimori T et al (2010) RRR study investigators. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 69:1286\u20131291","journal-title":"Ann Rheum Dis"},{"key":"3413_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-015-0707-1","volume":"17","author":"G Nagy","year":"2015","unstructured":"Nagy G, van Vollenhoven R (2015) Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now? Arthritis Research & Therapy 17:181","journal-title":"Arthritis Research & Therapy"},{"key":"3413_CR5","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"AK Brown","year":"2008","unstructured":"Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG et al (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58:2958\u20132967","journal-title":"Arthritis Rheum"},{"key":"3413_CR6","doi-asserted-by":"publisher","unstructured":"Rech J, Hueber A, Finzel S, Englbrecht M et al (2015) Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment. Ann Rheum Dis 1\u20137. doi: 10.1136\/annrheumdis-2015-207900 .","DOI":"10.1136\/annrheumdis-2015-207900"},{"key":"3413_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/ard.2008.106658","volume":"69","author":"JE Freeston","year":"2010","unstructured":"Freeston JE, Wakefield RJ, Conaghan PG, Hensor EM, Stewart SP, Emery PA (2010) Diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis 69:417\u2013419","journal-title":"Ann Rheum Dis"},{"key":"3413_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.2010.131573","volume":"70","author":"A Filer","year":"2011","unstructured":"Filer A, de Pablo P, Allen G, Nightingale P, Jordan A, Jobanputra P et al (2011) Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 70:500\u2013507","journal-title":"Ann Rheum Dis"},{"key":"3413_CR9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.37848","volume":"65","author":"D Nakagomi","year":"2013","unstructured":"Nakagomi D, Ikeda K, Okubo A, Iwamoto T, Sanayama Y, Takahashi K et al (2013) Ultrasound can improve the accuracy of the 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis to predict the requirement for methotrexate treatment. Arthritis Rheum 65:890\u2013898","journal-title":"Arthritis Rheum"},{"key":"3413_CR10","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.23682","volume":"58","author":"E Naredo","year":"2008","unstructured":"Naredo E, Moller I, Cruz A, Carmona L, Garrido J (2008) Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 58:2248\u20132256","journal-title":"Arthritis Rheum"},{"key":"3413_CR11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/annrheumdis-2011-201048","volume":"71","author":"RJ Wakefield","year":"2012","unstructured":"Wakefield RJ, D\u2019Agostino MA, Naredo E, Buch MH, Iagnocco A, Terslev L et al (2012) After treat-to-target: can a targeted ultrasound initiative improve RA outcomes? Ann Rheum Dis 71:799\u2013803","journal-title":"Ann Rheum Dis"},{"key":"3413_CR12","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3899\/jrheum.130556","volume":"40","author":"K Ikeda","year":"2013","unstructured":"Ikeda K, Nakagomi D, Sanayama Y, Yamagata M, Okubo A, Iwamoto T et al (2013) Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents. J Rheumatol 40:1967\u20131976","journal-title":"J Rheumatol"},{"key":"3413_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ard.2010.129924","volume":"70","author":"G Peluso","year":"2011","unstructured":"Peluso G, Michelutti A, Bosello S, Gremese E, Tolusso B, Ferraccioli G (2011) Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis 70:172\u2013175","journal-title":"Ann Rheum Dis"},{"key":"3413_CR14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/ard.2009.117341","volume":"69","author":"B Saleem","year":"2010","unstructured":"Saleem B, Keen H, Goeb V, Parmar R, Nizam S, Hensor EM et al (2010) Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann Rheum Dis 69:1636\u20131642","journal-title":"Ann Rheum Dis"},{"key":"3413_CR15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"3413_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML (1995) Van \u2018t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"3413_CR17","first-page":"734","volume":"28","author":"Y El Miedany","year":"2010","unstructured":"El Miedany Y, El Gaafary M, Youssef S, Palmer D (2010) Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis. Clin Exp Rheumatol 28:734\u2013744","journal-title":"Clin Exp Rheumatol"},{"key":"3413_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1573397111666150522095749","volume":"11","author":"YE El Miedany","year":"2015","unstructured":"El Miedany YE, Gaafary ME, Ahmed I, Youssef S, Nasr AUS (2015) Guided treat-to-target approach in early RA: implications for uncoupling of disease activity and structural joint damage. Curr Rheumatol Rev 11:18\u201327","journal-title":"Curr Rheumatol Rev"},{"key":"3413_CR19","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D\u2019Agostino MA et al (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32:2485\u20132487","journal-title":"J Rheumatol"},{"key":"3413_CR20","first-page":"v55v56","volume":"51","author":"J Smolen","year":"2012","unstructured":"Smolen J, Keystone E (2012) Future of RA: building on what we know and tailoring treatment. Rheumatology 51:v55v56","journal-title":"Rheumatology"},{"issue":"10","key":"3413_CR21","first-page":"S319","volume":"63","author":"Y El Miedany","year":"2011","unstructured":"El Miedany Y, El Gaafary M, Palmer D, Youssef S (2011) Imaging as an outcome measure in early inflammatory arthritis: monitoring disease activity and patients\u2019 response to therapy using ultrasonography. Arthritis. Rheumatism 63(10):S319","journal-title":"Rheumatism"},{"issue":"10","key":"3413_CR22","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/acr.22303","volume":"66","author":"T Iwamoto","year":"2014","unstructured":"Iwamoto T, Ideda K, Hosokawa J, Yamagata M (2014) Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total Gray-Scale and Power Doppler Scores that represent residual synovial inflammation before discontinuation. Arthritis Care Res 66(10):1576\u20131581","journal-title":"Arthritis Care Res"},{"issue":"Suppl3","key":"3413_CR23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/annrheumdis-2013-eular.680","volume":"72","author":"F Lamers-Karnebeek","year":"2013","unstructured":"Lamers-Karnebeek F, Jacobs H, Fransen J, Luime J, Riel P et al (2013) The post-US study: can ultrasonography predict flare inpatients with RA and persistent low disease activity in whom the TNF inhibitor (TNFi) is stopped? Preliminary results of an ongoing study. Ann Rheum Dis 72(Suppl3):214","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"3413_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/annrheumdis-2015-eular.5185","volume":"74","author":"F Lamers-Karnebeek","year":"2015","unstructured":"Lamers-Karnebeek F, Jansen T, van Riel P, Luime J, Jacobs J (2015) Ultrasonography as predictor for flare in rheumatoid arthritis patients with low disease activity: nine month results from post-US- study. Ann Rheum Dis 74(Suppl2):140","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"3413_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/annrheumdis-2016-eular.5031","volume":"75","author":"F Lamers-Karnebeek","year":"2016","unstructured":"Lamers-Karnebeek F, Luime J, van Riel P, Jacobs J, Jansen T (2016) Prediction of flare after stopping TNF-inhibitor by baseline ultrasonography and patient characteristics in rheumatoid arthritis patients with low disease activity: 12-month results. Ann Rheum Dis 75(Suppl2):125","journal-title":"Ann Rheum Dis"},{"key":"3413_CR26","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/ar4315","volume":"15","author":"S Hirata","year":"2013","unstructured":"Hirata S, Saito K, Kubo S et al (2013) Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study. Arthritis Res Ther 15:R135","journal-title":"Arthritis Res Ther"},{"key":"3413_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/annrheumdis-2014-206439","volume":"75","author":"J Haschka","year":"2016","unstructured":"Haschka J, Englbrecht M, Hueber A et al (2016) Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis 75:45\u201351","journal-title":"Ann Rheum Dis"},{"key":"3413_CR28","doi-asserted-by":"crossref","unstructured":"El Miedany Y, El Gaafary M, Sayed S, Ahmed I, Nasr A, Palmer D (2014) Functional disability: a parameter fit to be a biomarker for inflammatory arthritis. Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2014-eular.1470"},{"issue":"2","key":"3413_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jbspin.2007.04.021","volume":"75","author":"Y El Miedany","year":"2007","unstructured":"El Miedany Y, Youssef S, Mehanna A, El Gaafary M (2007) Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis. Joint Bone Spine 75(2):155\u2013162","journal-title":"Joint Bone Spine"},{"key":"3413_CR30","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.24661","volume":"60","author":"D Woude van der","year":"2009","unstructured":"van der Woude D, Young A, Jayakumar K et al (2009) Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 60:2262\u20132271","journal-title":"Arthritis Rheum"},{"key":"3413_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2010.136556","volume":"70","author":"NB Klarenbeek","year":"2011","unstructured":"Klarenbeek NB, van der Kooij SM, Guler-Yuksel M et al (2011) Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 70:315\u2013319","journal-title":"Ann Rheum Dis"},{"key":"3413_CR32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ard.2008.092254","volume":"68","author":"SM Kooij van der","year":"2009","unstructured":"van der Kooij SM, Goekoop-Ruiterman YP (2009) De Vries-Bouwstra JK, et al. drug-free remission, functioning and radiographic damage after 4\u00a0years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68:914\u2013921","journal-title":"Ann Rheum Dis"},{"key":"3413_CR33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492\u2013509","journal-title":"Ann Rheum Dis"},{"key":"3413_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/annrheumdis-2014-206696","volume":"75","author":"B Fautrel","year":"2016","unstructured":"Fautrel B, Pham T, Alfaiate T et al (2016) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: spacing of TNF-blocker injections in Rheumatoid Arthritis Study. Ann Rheum Dis 75:59\u201367","journal-title":"Ann Rheum Dis"},{"key":"3413_CR35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2014-205726","volume":"75","author":"RF Vollenhoven van","year":"2016","unstructured":"van Vollenhoven RF, \u00d8stergaard M, Leirisalo-Repo M et al (2016) Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis. Ann Rheum Dis 75:52\u201358","journal-title":"Ann Rheum Dis"},{"key":"3413_CR36","doi-asserted-by":"crossref","first-page":"h1389","DOI":"10.1136\/bmj.h1389","volume":"350","author":"N Herwaarden van","year":"2015","unstructured":"van Herwaarden N, van der Maas A, Minten MJ et al (2015) Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ 350:h1389","journal-title":"BMJ"},{"key":"3413_CR37","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/art.39626","volume":"68","author":"M Moghadam","year":"2016","unstructured":"Moghadam M, Vonkeman H, ten Klooster P, Tekstra J et al (2016) Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity. Arthritis Rheumatology 68:1810\u20131817","journal-title":"Arthritis Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3413-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T20:37:12Z","timestamp":1749587832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3413-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3413"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3413-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}